Sfoglia per Autore
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
2004 Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Palareti G; Tura S; Baccarani M.
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
2004 ZINZANI PL; FANTI S; BATTISTA G; TANI M; CASTELLUCCI P; STEFONI V; ALINARI L; FARSAD M; MUSURACA G; GABRIELE A; MARCHI E; NANNI C; CANINI R.; MONETTI N; BACCARANI M
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia
2004 ROSTI G.; MARTINELLI G.; BASSI S.; AMABILE M.; TRABACCHI E.; GIANNINI B.; CILLONI D.; IZZO B.; DE VIVO A.; TESTONI N.; CAMBRIN G. R.; BONIFAZI F.; SOVERINI S.; LUATTI S.; GOTTARDI E.; ALBERTI D.; PANE F.; SALVATORE F.; SAGLIO G.; BACCARANI M.; STUDY COMMITTEE; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA ; WRITING COMMITTEE;
Soft tissue and skeletal involvement in FIP1L1-PDGFR-A positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission
2004 MALAGOLA M; MARTINELLI G.; RONDONI M; OTTAVIANI E; PICCALUGA PP; RICCI P; VISANI G; BACCARANI M.
Amifostine feasibility and efficacy in autologous stem cell transplantation for multiple myeloma.
2004 STOCCHI R; DAMIANI D; MASOLINI P; MICHELUTTI A; BACCARANI M.; TOSI P; FANIN R.
Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely.
2004 MARTINELLI G; RONDONI M; BUONAMICI S; OTTAVIANI E; PICCALUGA PP; MALAGOLA M; BACCARANI M.
Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation.
2004 CILLONI D; MESSA F; GOTTARDI E; FAVA M; ARRUGA F; DEFILIPPI I; CARTURAN S; MESSA E; MOROTTI A; GIUGLIANO E; REGE-CAMBRIN G; ALBERTI D; BACCARANI M.; SAGLIO G.
Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo.
2004 LEMOLI RM; FERRARI D; FOGLI M; ROSSI L; PIZZIRANI C; FORCHAP S; CHIOZZI P; VASELLI D; BERTOLINI F; FOUTZ T; ALUIGI M; BACCARANI M.; DI VIRGILIO F.
Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
2004 A.CURTI; A. ISIDORI; E. FERRI; C. TERRAGNA; NEYROZ P.; C. CELLINI; M. RATTA; M. BACCARANI; R. M. LEMOLI
18F-FDG PET early after radiotherapy in lymphoma patients.
2004 CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MARENGO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S.
The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients.
2004 PICCALUGA PP; MALAGOLA M; AMABILE M; RONDONI M; PAOLINI S; PANE F; RUSSO D; VISANI G; BACCARANI M.; MARTINELLI G.
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
2004 TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M.
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
2004 ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M.
Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma
2004 Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A.
Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation.
2004 PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BIANCHINI M; VIGNA E; BOSI C; GAITANI S; VISANI G; BACCARANI M.
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.
2004 MARTINELLI G; MALAGOLA M; OTTAVIANI E; ROSTI G; TRABACCHI E; BACCARANI M.
First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients.
2004 PICCALUGA PP; MARTINELLI G; RONDONI M; MALAGOLA M; GAITANI S; VISANI G; BACCARANI M.
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
2004 PICCALUGA PP; MARTINELLI G.; RONDONI M; MALAGOLA M; GAITANI S; ISIDORI A; BONINI A; GUGLIOTTA L; LUPPI M; MORSELLI M; SPARAVENTI G; VISANI G; BACCARANI M.
Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission.
2004 BUONAMICI S; OTTAVIANI E; VISANI G; BONIFAZI F; FIACCHINI M; BACCARANI M.; MARTINELLI G.
Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia
2004 PICCALUGA PP; LUATTI S; ASCANI S; BIANCHINI M; MALAGOLA M; RONDONI M; GAITANI S; TESTONI N.; PILERI SA; BACCARANI M; MARTINELLI G; VISANI G
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma. | Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Pa...lareti G; Tura S; Baccarani M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. | ZINZANI PL; FANTI S; BATTISTA G; TANI M; CASTELLUCCI P; STEFONI V; ALINARI L; FARSAD M; MUSURACA ...G; GABRIELE A; MARCHI E; NANNI C; CANINI R.; MONETTI N; BACCARANI M | 2004-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Molecular response to imatinib in late chronic-phase chronic myeloid leukemia | ROSTI G.; MARTINELLI G.; BASSI S.; AMABILE M.; TRABACCHI E.; GIANNINI B.; CILLONI D.; IZZO B.; DE... VIVO A.; TESTONI N.; CAMBRIN G. R.; BONIFAZI F.; SOVERINI S.; LUATTI S.; GOTTARDI E.; ALBERTI D.; PANE F.; SALVATORE F.; SAGLIO G.; BACCARANI M.; STUDY COMMITTEE; ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA ; WRITING COMMITTEE; | 2004-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Soft tissue and skeletal involvement in FIP1L1-PDGFR-A positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission | MALAGOLA M; MARTINELLI G.; RONDONI M; OTTAVIANI E; PICCALUGA PP; RICCI P; VISANI G; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | ECR25.full.pdf |
| Amifostine feasibility and efficacy in autologous stem cell transplantation for multiple myeloma. | STOCCHI R; DAMIANI D; MASOLINI P; MICHELUTTI A; BACCARANI M.; TOSI P; FANIN R. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Molecular monitoring to identify a threshold of CBFbeta/MYH11 transcript below which continuous complete remission of acute myeloid leukemia inv16 is likely. | MARTINELLI G; RONDONI M; BUONAMICI S; OTTAVIANI E; PICCALUGA PP; MALAGOLA M; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation. | CILLONI D; MESSA F; GOTTARDI E; FAVA M; ARRUGA F; DEFILIPPI I; CARTURAN S; MESSA E; MOROTTI A; GI...UGLIANO E; REGE-CAMBRIN G; ALBERTI D; BACCARANI M.; SAGLIO G. | 2004-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. | LEMOLI RM; FERRARI D; FOGLI M; ROSSI L; PIZZIRANI C; FORCHAP S; CHIOZZI P; VASELLI D; BERTOLINI F...; FOUTZ T; ALUIGI M; BACCARANI M.; DI VIRGILIO F. | 2004-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy. | A.CURTI; A. ISIDORI; E. FERRI; C. TERRAGNA; NEYROZ P.; C. CELLINI; M. RATTA; M. BACCARANI; R. M. ...LEMOLI | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| 18F-FDG PET early after radiotherapy in lymphoma patients. | CASTELLUCCI P; ZINZANI P; NANNI C; FARSAD M; MORETTI A; ALINARI L; BATTISTA G; PETTINATO C; MAREN...GO M; BOSCHI S; CANINI R; BACCARANI M.; MONETTI N; FANTI S. | 2004-01-01 | CANCER BIOTHERAPY & RADIOPHARMACEUTICALS | - | 1.01 Articolo in rivista | - |
| The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients. | PICCALUGA PP; MALAGOLA M; AMABILE M; RONDONI M; PAOLINI S; PANE F; RUSSO D; VISANI G; BACCARANI M....; MARTINELLI G. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure. | TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M. | 2004-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. | ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M. | 2004-01-01 | CANCER | - | 1.01 Articolo in rivista | - |
| Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma | Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P....; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A. | 2004-01-01 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| Anti-leukemic and anti-GVHD effects of campath-1H in acute lymphoblastic leukemia relapsed after stem-cell transplantation. | PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BIANCHINI M; VIGNA E; BOSI C; GAITANI S; VISAN...I G; BACCARANI M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome. | MARTINELLI G; MALAGOLA M; OTTAVIANI E; ROSTI G; TRABACCHI E; BACCARANI M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients. | PICCALUGA PP; MARTINELLI G; RONDONI M; MALAGOLA M; GAITANI S; VISANI G; BACCARANI M. | 2004-01-01 | LEUKEMIA RESEARCH | - | 1.01 Articolo in rivista | - |
| Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas | PICCALUGA PP; MARTINELLI G.; RONDONI M; MALAGOLA M; GAITANI S; ISIDORI A; BONINI A; GUGLIOTTA L; ...LUPPI M; MORSELLI M; SPARAVENTI G; VISANI G; BACCARANI M. | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Patterns of AML1-ETO transcript expression in patients with acute myeloid leukemia and t(8;21) in complete hematologic remission. | BUONAMICI S; OTTAVIANI E; VISANI G; BONIFAZI F; FIACCHINI M; BACCARANI M.; MARTINELLI G. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia | PICCALUGA PP; LUATTI S; ASCANI S; BIANCHINI M; MALAGOLA M; RONDONI M; GAITANI S; TESTONI N.; PILE...RI SA; BACCARANI M; MARTINELLI G; VISANI G | 2004-01-01 | CANCER GENETICS AND CYTOGENETICS | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile